secondary prevention of coronary artery disease Flashcards
What is the main goal of secondary prevention of coronary artery disease
Stablize existing plaques (to prevent rupture) and prevent future plaques from forming
What are the classifications and levels of evidence assigned to guidelines
Classification: I – Should do it, IIa – Reasonable, IIb – Might be considered, III – Don’t do it. Levels of evidence: A – Several randomized trials, B – Observational studies, case reports, C – Expert opinion
What are the pharmacologic CAD secondary prevention guidelines? General
anti-platelets, Beta blockers, RAAS inhibitors
What are the pharmacologic and lifestyle CAD secondary prevention guidelines? General
BP control, lipid management, diabetes control, depression treatment, smoking cessation
What are the lifestyle CAD secondary prevention guidelines? General
Weight management, physical activity
Which antiplatelets are used in CAD secondary prevention and how do they work
Aspirin reduces platelet activation by blocking cyclooxygenase and thromboxane A2 (a vasoconstrictor) production. Thienopyridines ((clopidogrel, ticlodipine, prasugrel, and ticagrelor) block P2Y12 and inhibits adenosine diphosphate (ADP) production and platelet aggregation
Aspirin reduces platelet activation by blocking cyclooxygenase and thromboxane A2 (a vasoconstrictor) production. Thienopyridines ((clopidogrel, ticlodipine, prasugrel, and ticagrelor) block P2Y12 and inhibits adenosine diphosphate (ADP) production and platelet aggregation
Class I beta blocker guidelines
•Beta-blockers in all with Left ventricular systolic dysfunction (ejection fraction <40%) and heart failure symptoms or MI/ACS in the prior 3 years
Class Iia beta blocker guidelines
•Beta-blockers in all with Left ventricular systolic dysfunction (ejection fraction <40%) even in the absence of heart failure symptoms. Beta-blockers in all with any history of MI/ACS
How does RAAS blockade affect the CV system
Vasodilation, natriuresis, decreased SNS activity,reduces cardiac remodeling
Class 1 RAAS inhibition guidelines
ACEIs: All with Left Ventricular Systolic Dysfunction (ejection fraction <40%) who are receiving therapeutic doses of BB and ACEI/ARB and have heart failure or diabetes
What is the recommended BP to prevent cardiac events
< 140/90 if less than 60yrs. <150/90 if greater than 60 yrs
Interventions used to lower BP
lifestyle, RAAS inhibitors (ACEIs, ARBs), Beta-blockers, Diuretics, Calcium channel blockers, Direct vasodilators
lifestyle, RAAS inhibitors (ACEIs, ARBs), Beta-blockers, Diuretics, Calcium channel blockers, Direct vasodilators
class I lipid guidelines
Statins in all CAD patients. High dose if 75yrs. No need to titrate to LDL, no non-statins,
Does glycemic control affect MI outcomes?
No
Class I diabetes guidelines
•Lifestyle modifications and coordination with the patient’s primary care physician should occur